Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications

被引:10
|
作者
Friberger, Ida [1 ]
Jussing, Emma [2 ,3 ]
Han, Jinming [1 ,4 ]
Goos, Jeroen A. C. M. [1 ,2 ,3 ]
Siikanen, Jonathan [2 ,5 ]
Kaipe, Helen [6 ,7 ]
Lambert, Melanie [8 ]
Harris, Robert A. [1 ,4 ]
Samen, Erik [2 ,3 ]
Carlsten, Mattias [8 ,9 ]
Holmin, Staffan [1 ,10 ]
Tran, Thuy A. [1 ,2 ,3 ]
机构
[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[2] Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Radiopharm, Stockholm, Sweden
[4] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden
[5] Karolinska Univ Hosp, Dept Med Radiat Phys & Nucl Med, Stockholm, Sweden
[6] Karolinska Inst, Dept Lab Med, Stockholm, Sweden
[7] Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, Stockholm, Sweden
[8] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden
[9] Karolinska Univ Hosp, Ctr Cell Therapy & Allogene Stem Cell Transplanta, Stockholm, Sweden
[10] Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Cell labelling; Cell tracking; Zr-89; Oxine; Deferoxamine; PET; Imaging; DONOR LYMPHOCYTE INFUSION; DECIDUAL STROMAL CELLS; TRACKING; LEUKOCYTES; PET; CYTOTOXICITY; LEUKEMIA; RELAPSE;
D O I
10.1007/s11307-021-01622-z
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background There is a need to better characterise cell-based therapies in preclinical models to help facilitate their translation to humans. Long-term high-resolution tracking of the cells in vivo is often impossible due to unreliable methods. Radiolabelling of cells has the advantage of being able to reveal cellular kinetics in vivo over time. This study aimed to optimise the synthesis of the radiotracers [Zr-89]Zr-oxine (8-hydroxyquinoline) and [Zr-89]Zr-DFO-NCS (p-SCN-Bn-Deferoxamine) and to perform a direct comparison of the cell labelling efficiency using these radiotracers. Procedures Several parameters, such as buffers, pH, labelling time and temperature, were investigated to optimise the synthesis of [Zr-89]Zr-oxine and [Zr-89]Zr-DFO-NCS in order to reach a radiochemical conversion (RCC) of >95 % without purification. Radio-instant thin-layer chromatography (iTLC) and radio high-performance liquid chromatography (radio-HPLC) were used to determine the RCC. Cells were labelled with [Zr-89]Zr-oxine or [Zr-89]Zr-DFO-NCS. The cellular retention of Zr-89 and the labelling impact was determined by analysing the cellular functions, such as viability, proliferation, phagocytotic ability and phenotypic immunostaining. Results The optimised synthesis of [Zr-89]Zr-oxine and [Zr-89]Zr-DFO-NCS resulted in straightforward protocols not requiring additional purification. [Zr-89]Zr-oxine and [Zr-89]Zr-DFO-NCS were synthesised with an average RCC of 98.4 % (n = 16) and 98.0 % (n = 13), respectively. Cell labelling efficiencies were 63.9 % (n = 35) and 70.2 % (n = 30), respectively. Zr-89 labelling neither significantly affected the cell viability (cell viability loss was in the range of 1-8 % compared to its corresponding non-labelled cells, P value > 0.05) nor the cells' proliferation rate. The phenotype of human decidual stromal cells (hDSC) and phagocytic function of rat bone-marrow-derived macrophages (rMac) was somewhat affected by radiolabelling. Conclusions Our study demonstrates that [Zr-89]Zr-oxine and [Zr-89]Zr-DFO-NCS are equally effective in cell labelling. However, [Zr-89]Zr-oxine was superior to [Zr-89]Zr-DFO-NCS with regard to long-term stability, cellular retention, minimal variation between cell types and cell labelling efficiency.
引用
收藏
页码:952 / 962
页数:11
相关论文
共 17 条
  • [11] Novel 89Zr cell labeling approach for PET-based cell trafficking studies
    Aditya Bansal
    Mukesh K Pandey
    Yunus E Demirhan
    Jonathan J Nesbitt
    Ruben J Crespo-Diaz
    Andre Terzic
    Atta Behfar
    Timothy R DeGrado
    EJNMMI Research, 5
  • [12] Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
    Sarah R. Verhoeff
    Suzanne C. van Es
    Eline Boon
    Erik van Helden
    Lindsay Angus
    Sjoerd G. Elias
    Sjoukje F. Oosting
    Erik H. Aarntzen
    Adrienne H. Brouwers
    Thomas C. Kwee
    Sandra Heskamp
    Otto S. Hoekstra
    Henk Verheul
    Astrid A. M. van der Veldt
    Elisabeth G. E. de Vries
    Otto C. Boerman
    Winette T. A. van der Graaf
    Wim J. G. Oyen
    Carla M. L. van Herpen
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1931 - 1939
  • [13] Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
    Verhoeff, Sarah R.
    van Es, Suzanne C.
    Boon, Eline
    van Helden, Erik
    Angus, Lindsay
    Elias, Sjoerd G.
    Oosting, Sjoukje F.
    Aarntzen, Erik H.
    Brouwers, Adrienne H.
    Kwee, Thomas C.
    Heskamp, Sandra
    Hoekstra, Otto S.
    Verheul, Henk
    van der Veldt, Astrid A. M.
    de Vries, Elisabeth G. E.
    Boerman, Otto C.
    van der Graaf, Winette T. A.
    Oyen, Wim J. G.
    van Herpen, Carla M. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (09) : 1931 - 1939
  • [14] [89Zr]Oxinate4 for long-term in vivo cell tracking by positron emission tomography
    Putthiporn Charoenphun
    Levente K. Meszaros
    Krisanat Chuamsaamarkkee
    Ehsan Sharif-Paghaleh
    James R. Ballinger
    Trevor J. Ferris
    Michael J. Went
    Gregory E. D. Mullen
    Philip J. Blower
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 278 - 287
  • [15] 89Zr-leukocyte labelling for cell trafficking: in vitro and preclinical investigations
    Maryke Kahts
    Hua Guo
    Harikrishna Kommidi
    Yanping Yang
    Haluk Burcak Sayman
    Beverley Summers
    Richard Ting
    Jan Rijn Zeevaart
    Mike Sathekge
    Omer Aras
    EJNMMI Radiopharmacy and Chemistry, 8
  • [16] Radiation Dosimetry Study of [89Zr]rituximab Tracer for Clinical Translation of B cell NHL Imaging using Positron Emission Tomography
    Natarajan, Arutselvan
    Gambhir, Sanjiv Sam
    MOLECULAR IMAGING AND BIOLOGY, 2015, 17 (04) : 539 - 547
  • [17] A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr - In vitro stability and in vivo microPET/CT imaging studies in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts
    Cho, Hyungjun
    Al-Saden, Noor
    Lam, Heather
    MObus, Juri
    Reilly, Raymond M.
    Winnik, Mitchell A.
    NUCLEAR MEDICINE AND BIOLOGY, 2020, 84-85 : 11 - 19